An improved catalogue for whole-genome sequencing prediction of bedaquiline resistance in Mycobacterium tuberculosis using a reproducible algorithmic approach
Adlard D. et al, (2025), Microbial Genomics, 11
Erratum: Comparison of R9.4.1/Kit10 and R10/Kit12 Oxford Nanopore flowcells and chemistries in bacterial genome reconstruction
Sanderson ND. et al, (2023), Microbial Genomics, 9
Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes
Cotton S. et al, (2023), Journal of Hospital Infection, 135, 28 - 36
The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis
Pascall DJ. et al, (2023), PLOS ONE, 18, e0284187 - e0284187
Comparison of R9.4.1/Kit10 and R10/Kit12 Oxford Nanopore flowcells and chemistries in bacterial genome reconstruction
Sanderson ND. et al, (2023), Microbial Genomics, 9
Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Willett BJ. et al, (2022), Nature Microbiology, 7, 1709 - 1709
Author Correction: SARS-CoV-2 evolution during treatment of chronic infection
Kemp SA. et al, (2022), Nature, 608, E23 - E23
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Collier DA. et al, (2022), Nature, 608, E24 - E24
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Tuekprakhon A. et al, (2022), Cell, 185, 2422 - 2433.e13
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18
Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Tuekprakhon A. et al, (2022)
SARS-CoV-2 Testing in the Community: Testing Positive Samples with the TaqMan SARS-CoV-2 Mutation Panel To Find Variants in Real Time
Ashford F. et al, (2022), Journal of Clinical Microbiology, 60
Tracking SARS-CoV-2 Mutations & Variants Through the COG-UK-Mutation Explorer
Wright DW. et al, (2022), Virus Evolution
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Twohig KA. et al, (2022), The Lancet Infectious Diseases, 22, 35 - 42
How to sequence 10,000 bacterial genomes and retain your sanity: an accessible, efficient and global approach
Perez-Sepulveda BM. et al, (2022), Access Microbiology, 4
Rapid turnaround multiplex sequencing of SARS-CoV-2: comparing tiling amplicon protocol performance
Constantinides B. et al, (2022)